Clinical Trials Browser

Observational × liposomal doxorubicin × Sarcoma × Clear all

NCT04055753 2026-05-22

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active not recruiting

Sarcoma